1. MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks.
- Author
-
Li, Wenbin, Li, Jing, Wang, Rong, Xie, Hua, and Jia, Zhengping
- Subjects
PHARMACOKINETICS ,MULTIDRUG resistance ,HYPOXEMIA ,TRANSCRIPTION factors ,ANDROSTANE receptors ,MICRORNA ,GENETIC regulation - Abstract
Some newest studies indicated that drug transports may play the key role in pharmacokinetics changes under hypoxia at high altitude; MDR1 is now known to affect the disposition of many administered drugs and make a major contribution to absorption, distribution, metabolism, excretion. Different expression of MDR1 is frequently found in different normal tissues and tumor cells; it is important to better understand how MDR1 is regulated under hypoxia, which seems to be a complex and highly controlled process. Several signaling pathways and transcription factors have been described as being involved in the regulation of MDR1 expression, such as MAPK/ERK, nuclear factor-kappaB, hypoxia-inducible factor-1a, pregnane × receptor, constitutive androstane receptor and microRNA. Recently, researches have been increasingly appreciating long non-coding RNAs (lncRNAs) as an integral component of gene regulatory networks. lncRNAs play crucial roles in various biological processes ranging from epigenetic gene regulation, transcriptional control, post-transcriptional regulation, pre-mRNA processing and nuclear organization. A last recent research showed that H19 gene non-coding RNA is believed to induce P-glycoprotein expression under hypoxia. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF